Maneka Mirchandaney

Stock Analyst at Evercore ISI Group

(0.27)
# 4,119
Out of 4,854 analysts
7
Total ratings
28.57%
Success rate
-28.86%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Maneka Mirchandaney

Crinetics Pharmaceuticals
Sep 11, 2023
Maintains: Outperform
Price Target: $41$48
Current: $33.00
Upside: +45.45%
MiNK Therapeutics
Mar 22, 2023
Maintains: Outperform
Price Target: $40$30
Current: $7.39
Upside: +305.95%
Incyte
Aug 3, 2022
Downgrades: In-Line
Price Target: $90$78
Current: $68.76
Upside: +13.44%
Viridian Therapeutics
Oct 12, 2021
Initiates: Outperform
Price Target: $40
Current: $14.68
Upside: +172.48%
Werewolf Therapeutics
May 25, 2021
Initiates: Outperform
Price Target: $23
Current: $1.42
Upside: +1,519.72%